Cargando…

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Roccato, E, Miranda, C, Ranzi, V, Gishizki, M, Pierotti, M A, Greco, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984460/ https://www.ncbi.nlm.nih.gov/pubmed/27228298 http://dx.doi.org/10.1038/bjc.2016.131

Ejemplares similares

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc
por: Roccato, E, et al.
Publicado: (2002)

Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes
por: Miranda, Claudia, et al.
Publicado: (2010)

Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity
por: Scarpi, D, et al.
Publicado: (2012)

Ras, TrkB, and ShcA Protein Expression Patterns in Pediatric Brain Tumors
por: Prill, Monika, et al.
Publicado: (2021)

Corrigendum to “Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc” [Redox Biol. 13 (2017) 482–497]
por: Yang, Shikun, et al.
Publicado: (2019)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions
por: Pomerleau, Véronique, et al.
Publicado: (2014)

Low Frequency of Rearrangements of the ret and trk Proto‐oncogenes in Japanese Thyroid Papillary Carcinomas
por: Wajjwalku, Worawidh, et al.
Publicado: (1992)

Corrigendum to: Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
Publicado: (2021)

P66Shc signals to age
por: Trinei, Mirella, et al.
Publicado: (2009)

Targeting BRAF in thyroid cancer
por: Espinosa, A V, et al.
Publicado: (2007)

On the right TRK: from oncogene discovery to cancer therapeutics
por: Barbacid, M
Publicado: (2019)

Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
por: Gitenay, D, et al.
Publicado: (2014)

Oncogenic role of the Notch pathway in primary liver cancer (Review)
por: Lu, Jie, et al.
Publicado: (2016)

PortEco: a resource for exploring bacterial biology through high-throughput data and analysis tools
por: Hu, J.C., et al.
Publicado: (2014)

Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells
por: Wu, Yuan, et al.
Publicado: (2019)

Corrigendum to “The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma”
por: You, Jia, et al.
Publicado: (2019)

Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma
por: Wang, Ke, et al.
Publicado: (2022)

MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

Corrigendum to “PAX3: A Molecule with Oncogenic or Tumor Suppressor Function Is Involved in Cancer”
por: Arasu, Ashok, et al.
Publicado: (2019)

BMP9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling
Publicado: (2023)

Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma
por: Zhu, Wenyi, et al.
Publicado: (2019)

Corrigendum to “Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease”
por: Feldt-Rasmussen, Ulla, et al.
Publicado: (2017)

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
por: White, N M A, et al.
Publicado: (2017)

Endothelial FAK is required for tumour angiogenesis
por: Tavora, Bernardo, et al.
Publicado: (2016)

ATHEROSCLEROSIS NEEDS SHC
por: Robinson, Richard
Publicado: (2008)

Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”
por: Prazeres, Hugo, et al.
Publicado: (2016)

Insights into the Shc Family of Adaptor Proteins
por: Ahmed, Samrein B. M., et al.
Publicado: (2017)

Bifurcation of Cell Migratory and Proliferative Signaling by the Adaptor Protein Shc
por: Collins, Lila R., et al.
Publicado: (1999)

Glucose regulates transcription in yeast through a network of signaling pathways
por: Zaman, Shadia, et al.
Publicado: (2009)

p66Shc in Cardiovascular Pathology
por: Haslem, Landon, et al.
Publicado: (2022)

Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
por: Sugimoto, Tohru, et al.
Publicado: (2001)

The Blood Biomarkers of Thyroid Cancer [Corrigendum]
Publicado: (2022)

Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway
por: Zhang, Jiao, et al.
Publicado: (2017)

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Publicado: (2017)

The oxidative stress adaptor p66Shc is required for permanent embryo arrest in vitro
por: Favetta, Laura A, et al.
Publicado: (2007)

A novel requirement for DROSHA in maintenance of mammalian CG methylation
por: Stathopoulou, Athanasia, et al.
Publicado: (2017)

DNA cleavage by CgII and NgoAVII requires interaction between N- and R-proteins and extensive nucleotide hydrolysis
por: Zaremba, M., et al.
Publicado: (2015)

Long non‐coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling
por: Yao, Jin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_llbh8vdto6ub755euoercm680d